Chloroquine-resistant malaria

Journal of Infectious Diseases

Volumn 184, Issue 6, 2001, Pages 770-776

  Wellems, Thomas E ^a   Plowe, Christopher V ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; GENE PRODUCT; HEMATIN; QUININE;

DRUG EFFICACY; GENETIC COMPLEMENTATION; IMMUNITY; MALARIA; MUTATION; NONHUMAN; PHENOTYPE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; HUMANS; MALARIA; MALARIA, FALCIPARUM; PLASMODIUM; PLASMODIUM FALCIPARUM;

EID: 0035884456     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/322858     Document Type: Review

References (73)

1. Ueber die wirkung des methylenblau bei malaria
2. Antimalarial agents: Chemistry and pharmacology
3. Pitfalls in a discovery: The chronicle of chloroquine
4. Spread of chloroquine resistance in Plasmodium falciparum
5. Resistance in human malaria IV: 4-aminoquinolines and multiple resistance
6. Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire
7. Impact of chloroquine resistance on malaria mortality
8. Plasmodium vivax resistant to chloroquine?
9. Diagnosis of resistance to chloroquine by Plasmodium vivax: Timing of recurrence and whole blood chloroquine levels
10. Drug resistant Plasmodium vivax malaria
11. Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites
12. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials
13. The fate of ferriprotorphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs
14. On the molecular mechanism of chloroquine's antimalarial action
15. The structure of malaria pigment β-haematin
16. Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance
17. Efflux of chloroquine from Plasmodium falciparum: Mechanism of chloroquine resistance
18. Access to haematin: The basis of chloroquine resistance
19. Identification of a chloroquine importer in Plasmodium falciparum: Differences in import kinetics are genetically linked with the chloroquine-resistant phenotype
20. Verapamil reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum is specific for resistant parasites and independent of the weak base effect
21. Digestive vacuolar pH of intact intraerythrocytic P. falciparum either sensitive or resistant to chloroquine
22. Resistance in human malaria. III. Dihydrofolate reductase inhibitors
23. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine
24. Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7
25. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance
26. Conservation of a novel vacuolar transporter in Plasmodium species and its central role in chloroquine resistance of falciparum but not vivax malaria
27. A molecular marker for chloroquine-resistant falciparum malaria
28. Analysis of the key PfCRT point mutation and in vitro and in vivo response to chloroquine in Yaoundé;, Cameroon
29. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1
30. Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene, and its relation to chloroquine resistance in Mozambique
31. Analysis of the PfCRT K76T mutation in Plasmodium falciparum isolates from the Amazon region of Brazil
32. Polymorphisms in the Plasmodium falcipurum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda
33. Plasmodium falciparum malaria in Laos: Chloroquine treatment outcome and predictive value of molecular markers
34. Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum
35. Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum
36. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil
37. Drug sensitivity of Plasmodium falciparum: An in-vitro microtechnique
38. In vitro study of drug sensitivity of Plasmodium falciparum: Evaluation of a new semi-micro test
39. African serum interference in the determination of chloroquine sensitivity in Plasmodium falciparum
40. Chemotherapy of malaria and resistance to antimalarials
41. Assessment of therapeutic efficacy of antimalarial drugs
42. Response of Plasmodium falciparum to chloroquine treatment: Relation to whole blood concentrations of chloroquine and desethylchloroquine
43. In vitro assessment of the antimalarial activity of chloroquine and its major metabolites
44. Practical chemotherapy of malaria: Report of a WHO Scientific Group
45. Absence of malaria mortality in villagers with chloroquine-resistant Plasmodium falciparum treated with chloroquine
46. Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia
47. Polymorphism of the pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia
48. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa
49. Malaria: A neglected disease?
50. Parasitology
51. A study of induced malignant tertian malaria
52. The chemotherapy-immunity interface
53. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole
54. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum
55. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
56. Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa
57. Evidence for selection for the tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum by chloroquine and amodiaquine
58. Chloroquine-resistant Plasmodium falciparum isolates from the Sudan lack two mutations in the pfmdr1 gene thought to be associated with chloroquine resistance
59. Chloroquine resistance of Plasmodium falciparum: Further evidence for a lack of association with mutations of the pfmdr1 gene
60. Molecular epidemiology of malaria in Yaoundé;, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr1) gene of Plasmodium falciparum
61. Alleles of the Plasmodium falciparum pfmdr1 gene appear not to be associated with chloroquine resistance in India
62. Two mutations in the multidrug-resistance gene homologue of Plasmodium falciparum pfmdr1, are not useful predictors of in-vivo or in-vitro chloroquine resistance in southern Africa
63. 4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum
64. Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro
65. Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component
66. Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine
67. In vitro activities of chloroquine in combination with chlorpromazine or prochlorperazine against isolates of Plasmodium falciparum
68. Fluoxetine hydrochloride enhances in vitro susceptibility to chloroquine in resistant Plasmodium falciparum
69. In vitro reversal of chloroquine resistance with chlorpheniramine against African isolates of Plasmodium falciparum
70. Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncomplicated falciparum malaria in children
71. Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria
72. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria